[FHLC] Fidelity MSCI Health Care Index ETF

Overview

Type of security: Fund

Tags: Equity, ETF, Health, Health care, Index Based, Not Inversed, Stocks, Unleveraged

The data is delayed by 15 minutes.

 

Price: 33.23 Change: 0.34 (1.03%)
Ext. hours: Change: 0 (0%)

chart FHLC

Refresh chart

Strongest Trends Summary For FHLC

FHLC is in the medium-term up 5% above S&P in 2 months and down -10% below S&P in 6 months. In the long-term up 40% in 4 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

See how to gain 20% in 14 sec with TrendsInvesting

Technical Data
High 52 week46.76 Low 52 week38.66 Last close43.16 Last change-0.19%
RSI35.45 Average true range0.7 Beta0.99 Volume122.69 K
Simple moving average 20 days-0.77% Simple moving average 50 days-1.91% Simple moving average 200 days-1.69%
Performance Data
Performance Week3.43% Performance Month-1.82% Performance Quart1.99% Performance Half2.36%
Performance Year6.72% Performance Year-to-date4.82% Volatility daily1.05% Volatility weekly2.35%
Volatility monthly4.81% Volatility yearly16.67% Relative Volume280.11% Average Volume244.54 K
New High New Low
Funds Characteristics
30-day SEC yield Average market capitalization Average weighted market capitalization Forward P/E
Gross expense ratio Index dividend yield Median market cap Number of holdings
Price to Book Value Price to Earnings Total expense ratio Total net assets
Weighted market capitalization

News

2019-04-18 10:59:02 | Can Q1 Earnings Lift Healthcare ETFs Higher?

2019-03-05 12:04:20 | The 7 Best Healthcare ETFs for a Sector Rebound

2019-01-24 10:59:03 | Healthcare ETFs in Focus Ahead of Q4 Earnings

2018-12-28 09:27:02 | Healthcare and Value: 2 ETFs to Watch on Outsized Volume

2018-10-02 15:15:49 | The 7 Best ETFs of the Third Quarter

2018-08-14 06:00:41 | Debut of Zero-Fee Funds Puts Fidelity ETFs in the Spotlight Again

2018-08-03 15:27:07 | 12 U.S. Sector ETFs to Play in Case of an Escalating Trade War

2018-04-17 17:02:17 | Tech Advances Could Help Healthcare ETFs Grow

2018-04-17 11:49:14 | 7 Sector ETFs to Own Now

2018-04-03 14:59:54 | Fidelity Trims Fees on 3 Bond ETFs

2018-03-12 15:54:29 | Market Correction May Foreshadow Bullish Run for Stock ETFs

2017-11-06 09:02:00 | The 4 Most Promising ETFs for 2017 XLF, FHLC

2017-10-24 16:09:46 | What Analysts Recommend for Merck ahead of 3Q17 Earnings

2017-09-13 07:37:21 | Must-Know Recent Developments for Gilead

2017-09-08 10:37:28 | Inside Merck’s Segment-Wise Performance in 2Q17

2017-08-31 16:36:06 | Eli Lilly & Co.’s Revenues in 2Q17

2017-08-29 16:35:56 | Bristol-Myers Squibb’s Oncology Products in 2Q17

2017-08-29 10:39:01 | Johnson & Johnson’s Consumer Segment in 2Q17

2017-08-23 07:37:09 | How Allergan’s International Segment Performed in 2Q17

2017-08-15 07:36:43 | Pfizer’s Declining-Revenue Products in 2Q17

2017-08-01 10:36:13 | Eli Lilly’s Major Developments in 2Q17

2017-08-01 07:41:38 | Pfizer on the Street: Analyst Recommendations after 2Q17

2017-07-26 18:06:21 | Analysts’ Recommendations for Bristol-Myers Squibb in 2Q17

2017-07-24 10:11:02 | Surprise in Store for Healthcare in Q2: Buy Top-Ranked ETFs

2017-07-24 09:08:02 | Johnson & Johnson: Medical Devices in 2Q17

2017-07-19 11:55:03 | J&J Brightens Outlook: Healthcare ETFs in Focus

2017-07-17 09:07:21 | Johnson & Johnson’s 2Q17 Estimates: Medical Devices

2017-07-10 07:39:04 | How 2Q17 Is Shaping Up for Pfizer

2017-07-04 09:08:34 | Johnson & Johnson’s Segment-Wise Performance in 1Q17

2017-07-03 07:38:57 | Merck & Co. Reported 1% Growth in Its 1Q17 Revenues

2017-06-27 07:38:11 | Tanezumab Receives FDA Fast Track Designation

2017-06-20 15:36:10 | Updates on the Adcetris and Opdivo Combination

2017-06-19 07:36:40 | How Eli Lilly’s Taltz Performed in Clinical Trials

2017-06-13 07:36:15 | Akcea Therapeutics’ Volanesorsen: 1Q17 Performance

2017-06-01 09:09:20 | Eli Lilly & Co.’s Revenues in 1Q17

2017-05-31 09:08:53 | How Johnson & Johnson’s Consumer Segment Performed in 1Q17

2017-05-23 08:14:17 | A Close Look at Merck & Co.’s Valuation after 1Q17 Earnings

2017-05-08 07:37:17 | Pfizer: Understanding Growth Drivers in 1Q17

2017-05-03 07:35:53 | Is Eli Lilly & Co.’s Valuation Higher Than Its Peers?

2017-05-01 10:29:46 | What Do Analysts Expect from Merck’s 1Q17 Earnings?

2017-04-24 10:36:19 | Analyst Ratings and Recommendations for Eli Lilly

2017-04-24 10:06:02 | Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?

2017-04-20 15:35:43 | Johnson & Johnson’s 1Q17 Earnings: Changes in Its Growth Rate

2017-04-19 10:55:02 | Lackluster J&J Q1 Pushes Healthcare ETFs Down

2017-04-07 11:57:51 | Analyzing the Performance of Eli Lilly Stock in 1Q17

2017-03-17 09:06:35 | How BMY’s Virology Segment Performed in 2016

2017-03-16 13:09:00 | A Cost-Efficient Avenue to Health Care Exposure

2017-03-13 09:07:50 | Johnson & Johnson’s Revenue Trends

2017-03-10 08:00:27 | Growth Strategy Offers Seven Trump ETFs And 'Black Swan' Protection

2017-03-10 08:00:27 | Growth Strategy Offers Seven Trump ETFs And 'Black Swan' Protection

FHLC motifs

There is no motif for this symbol